IT1233412B - Uso del trazodone - Google Patents

Uso del trazodone

Info

Publication number
IT1233412B
IT1233412B IT8722856A IT2285687A IT1233412B IT 1233412 B IT1233412 B IT 1233412B IT 8722856 A IT8722856 A IT 8722856A IT 2285687 A IT2285687 A IT 2285687A IT 1233412 B IT1233412 B IT 1233412B
Authority
IT
Italy
Prior art keywords
trazodone
Prior art date
Application number
IT8722856A
Other languages
English (en)
Other versions
IT8722856A0 (it
Inventor
Bruno Silvestrini
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Priority to IT8722856A priority Critical patent/IT1233412B/it
Publication of IT8722856A0 publication Critical patent/IT8722856A0/it
Priority to EP88202680A priority patent/EP0335017A3/en
Priority to US07/277,058 priority patent/US4906632A/en
Priority to JP63305091A priority patent/JPH01211522A/ja
Application granted granted Critical
Publication of IT1233412B publication Critical patent/IT1233412B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT8722856A 1987-12-02 1987-12-02 Uso del trazodone IT1233412B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT8722856A IT1233412B (it) 1987-12-02 1987-12-02 Uso del trazodone
EP88202680A EP0335017A3 (en) 1987-12-02 1988-11-24 Novel use of trazodone
US07/277,058 US4906632A (en) 1987-12-02 1988-11-28 Method of preventing myocardial infarction and acute cerebral ischaemia
JP63305091A JPH01211522A (ja) 1987-12-02 1988-12-01 梗塞および急性脳虚血の予防薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8722856A IT1233412B (it) 1987-12-02 1987-12-02 Uso del trazodone

Publications (2)

Publication Number Publication Date
IT8722856A0 IT8722856A0 (it) 1987-12-02
IT1233412B true IT1233412B (it) 1992-03-30

Family

ID=11201237

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8722856A IT1233412B (it) 1987-12-02 1987-12-02 Uso del trazodone

Country Status (4)

Country Link
US (1) US4906632A (it)
EP (1) EP0335017A3 (it)
JP (1) JPH01211522A (it)
IT (1) IT1233412B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
RU2008113439A (ru) * 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
ITMI20071573A1 (it) * 2007-07-31 2009-02-01 Acraf Composizione farmaceutica liquida stabile a base di trazodone
ITMI20071603A1 (it) * 2007-08-03 2009-02-04 Acraf Trazodone e trazodone cloridrato in forma purificata
CN116549406B (zh) * 2023-05-23 2023-12-19 北京丰科睿泰医药科技有限公司 一种盐酸曲唑酮缓释片剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154832A (en) * 1974-08-26 1979-05-15 Bruno Silvestrini Novel treatment for acute organic cerebral syndromes (strokes)
AU8770282A (en) * 1981-08-27 1983-03-03 Shaun R. Coughlin Composition for the treatment of atherosclerosis
US4444778A (en) * 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
GB8717168D0 (en) * 1987-07-21 1987-08-26 Roussel Lab Ltd Controlled-release device

Also Published As

Publication number Publication date
JPH01211522A (ja) 1989-08-24
US4906632A (en) 1990-03-06
EP0335017A2 (en) 1989-10-04
IT8722856A0 (it) 1987-12-02
EP0335017A3 (en) 1990-07-25

Similar Documents

Publication Publication Date Title
PT88349A (pt) Winged napkin having cross-channeling
LV10614A (lv) 2-anilinopirimidina atvasinajumi
DK363887A (da) Anvendelse af bromcruptin
NO883142D0 (no) Anvendelse av olefiniske forbindelser.
DK507188A (da) Cholecalciferolderivater
DK383887D0 (da) Hidtil ukendte 18-phenyloestranderivater
TR23721A (tr) Alueminyum celat bilesiklerinin yumusakca oeldueruecue maddeler olarak kullanimi
DK378088D0 (da) Alkenderivater
KR890700128A (ko) 세팔로스포린 유도체
DK49688D0 (da) Propiolophenonderivater
IT1233412B (it) Uso del trazodone
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK271088D0 (da) Tienopyridinderivater
IT1239064B (it) Uso terapeutico del dipiridamolo
DK702188A (da) Ethanolaminderivater
DK695788D0 (da) Naphtalenderivater
DK71488A (da) Dipenylethylen-derivater
DK733688A (da) Dioxazocinderivater
SE8705060L (sv) Antiforkylningssats, antiforkylningspreparat och anvendning derav
DK629387D0 (da) Fremgangsmaade
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
DK313789A (da) Thiadiazinonderivater
SE8704882D0 (sv) New use
SE8702229D0 (sv) New use ii
BR6702346U (pt) Porta-guardanapos